Genmab appoints new CDO


Genmab appoints Judith Klimovsky as Executive Vice President and Chief Development Officer (CDO).

Klimovsky will lead the company’s global product development activities and will join the Executive team of Chief Executive Officer, Jan van de Winkel and Chief Financial Officer, David Eatwell.

Klimovsky comes from a role as Senior Vice President and Global Head, Oncology Clinical Development at Novartis.

She is a recognised drug development leader in the pharmaceutical industry and has previously served in senior roles at Merck and Bristol-Meyers Squibb. Klimovsky has also held positions in clinical practice in Buenos Aires, Argentina.

Sign up for your free email newsletter

Klimovsky will join Genmab on February 13, 2017 and will be based at the company’s Princeton, United States location, whilst travelling regularly to the company’s locations in Copenhagen, Denmark and Utrecht, The Netherlands.